|
Acetaminophen
poisoning can cause gastroenteritis within hours and hepatotoxicity
1 to 3 days after ingestion. Severity of hepatotoxicity after a
single acute overdose is predicted by serum acetaminophen levels.
Treatment is with N-acetylcysteine to prevent or
minimize hepatotoxicity.
Acetaminophen is contained in > 100 products sold OTC. Products include many children's preparations in liquid, tablet, and capsule form and many cough and cold preparations. Many prescription drugs also contain acetaminophen. Consequently, acetaminophen overdose is common.
Pathophysiology
The principal toxic metabolite of acetaminophen, N-acetyl-p-benzoquinone imine (NAPQI), is produced by the hepatic cytochrome P-450 enzyme system; glutathione stores in the liver detoxify this metabolite. An acute overdose depletes glutathione stores in the liver. As a result, NAPQI accumulates, causing hepatocellular necrosis and possibly damage to other organs (eg, kidneys, pancreas). Theoretically, alcoholic liver disease or undernutrition could increase risk of toxicity because hepatic enzyme preconditioning may increase formation of NAPQI and because undernutrition (also common among alcoholics) reduces hepatic glutathione stores. However, whether the risk is actually increased is unclear. Acute alcohol ingestion may be protective because hepatic P-450 enzymes preferentially metabolize ethanol and thus cannot produce toxic NAPQI.
Acute Acetaminophen
Poisoning
To cause toxicity, an acute overdose must total ≥ 150 mg/kg (about 7.5 g in adults) within 24 h.
Symptoms and Signs
Mild poisoning may not cause symptoms, and when present, symptoms are usually minor until ≥ 48 h after ingestion. Symptoms, which occur in 4 stages (see Table 5: Poisoning: Stages of Acute Acetaminophen Poisoning ), include anorexia, nausea, vomiting, and right upper quadrant abdominal pain. Renal failure and pancreatitis may occur, occasionally without liver failure. After > 5 days, hepatotoxicity resolves or progresses to multiple organ failure, which can be fatal.
|
Table 5
|
 | | |
|
Stages of Acute Acetaminophen
Poisoning
|
|
Stage
|
Time Post-ingestion
|
Description
|
|
I
|
0–24 h
|
Anorexia, nausea, vomiting
|
|
II
|
24–72 h
|
Right upper quadrant abdominal pain (common)
AST, ALT, and, if poisoning is severe, bilirubin and PT (usually reported as the INR) sometimes elevated
|
|
III
|
72–96 h
|
Vomiting and symptoms of liver failure
Peaking of AST, ALT, bilirubin, and INR
Sometimes renal failure and pancreatitis
|
|
IV
|
> 5 days
|
Resolution of hepatotoxicity or progression to multiple organ failure (sometimes fatal)
|
|
Diagnosis
Acetaminophen overdose should be considered in all patients with nonaccidental ingestions that may be suicide attempts because formulations containing acetaminophen are frequently ingested in such overdoses and are not reported. Also, acetaminophen often causes minimal symptoms during the early stages and is potentially lethal but treatable.
Likelihood and severity of hepatotoxicity caused by an acute ingestion can be predicted by the amount ingested or, more accurately, by the serum acetaminophen level. If the time of ingestion is known, the Rumack-Matthew nomogram (see Fig. 1: Poisoning: Rumack-Matthew nomogram for single acute acetaminophen poisoning. ) is used to estimate likelihood of hepatotoxicity; if the time of ingestion is unknown, the nomogram cannot be used. For a single acute overdose of traditional acetaminophen or rapid-relief acetaminophen (which is absorbed 7 to 8 min faster), levels are measured ≥ 4 h after ingestion and plotted on the nomogram. A level ≤ 150 μg/mL (≤ 990 μmol/L) and absence of toxic symptoms indicate that hepatotoxicity is very unlikely. Higher levels indicate possible hepatotoxicity. For a single acute overdose with extended-relief acetaminophen (which has 2 peak serum levels about 4 h apart), acetaminophen levels are measured ≥ 4 h after ingestion and 4 h later; if either level is above the Rumack-Matthew line of toxicity, treatment is required.
|
Fig. 1
|
| | |
|
Rumack-Matthew nomogram for single acute acetaminophen poisoning.
|
 |
|
Semilogarithmic plot of plasma acetaminophen levels vs time. Cautions for use of this chart: (1) The time coordinates refer to time of ingestion. (2) Serum levels drawn before 4 h may not represent peak levels. (3) The graph should be used only in relation to a single acute ingestion. (4) The lower solid line 25% below the standard nomogram is included to allow for possible errors in acetaminophen plasma assays and estimated time from ingestion of an overdose. Adapted from Rumack BH, Matthew H: Acetaminophen poisoning and toxicity. Pediatrics 55(6): 871–876, 1975; reproduced by permission of Pediatrics.
|
|
If poisoning is confirmed or strongly suspected, other tests are done. Liver function tests are done and, in suspected severe poisoning, PT is measured. AST and ALT results correlate with the stage of poisoning (see Table 5: Poisoning: Stages of Acute Acetaminophen Poisoning). AST levels > 1000 IU/L are more likely to result from acetaminophen poisoning than from chronic hepatitis or alcoholic liver disease. If poisoning is severe, bilirubin and INR may be elevated.
Prognosis
With appropriate treatment, mortality is uncommon.
Poor
prognostic indicators at 24 to 48 h postingestion include all of the following:
Acute acetaminophen toxicity does not predispose patients to cirrhosis.
Treatment
Activated charcoal may be given if acetaminophen is likely to still remain in the GI tract.
N- Acetylcysteine is an antidote for acetaminophen poisoning. This drug is a glutathione precursor that decreases acetaminophen toxicity by increasing hepatic glutathione stores and possibly via other mechanisms. It helps prevent hepatic toxicity by inactivating the toxic acetaminophen metabolite (NAPQI) before it can injure liver cells. However, it does not reverse damage to liver cells that has already occurred.
For acute poisoning, N- acetylcysteine is given if hepatotoxicity is likely based on acetaminophen dose or serum level. The drug is most effective if given within 8 h of acetaminophen ingestion. After 24 h, the benefit of the antidote is questionable.
N- Acetylcysteine is equally effective given IV or orally. IV therapy is given as a continuous infusion. A loading dose of 150 mg/kg in 200 mL of 5% D/W given over 15 min is followed by maintenance doses of 50 mg/kg in 500 mL of 5% D/W given over 4 h, then 100 mg/kg in 1000 mL of 5% D/W given over 16 h. For children, dosing may need to be adjusted to decrease the total volume of fluid delivered; consultation with a poison control center is recommended.
The oral loading dose of N- acetylcysteine is 140 mg/kg. This dose is followed by 17 additional doses of 70 mg/kg q 4 h. Oral acetylcysteine is unpalatable; it is given diluted 1:4 in a carbonated beverage or fruit juice and may still cause vomiting. If vomiting occurs, an antiemetic can be used; if vomiting occurs within 1 h of a dose, the dose is repeated. However, vomiting may be protracted and may limit oral use. Allergic reactions are unusual but have occurred with oral and IV use.
Liver failure is treated supportively. Patients with fulminant liver failure may require liver transplantation.
Chronic Acetaminophen Poisoning
Chronic excessive use or repeated overdoses cause hepatotoxicity in a few patients. Usually, chronic overdose is not an attempt at self-injury but instead results from taking inappropriately high doses to treat pain. Symptoms may be absent or may include any of those that occur with acute overdose.
Diagnosis
The Rumack-Matthew nomogram cannot be used, but likelihood of clinically significant hepatotoxicity can be estimated based on AST, ALT, and serum acetaminophen levels.
Treatment
The role of N- acetylcysteine in treatment of chronic acetaminophen toxicity or in the presence of established acute hepatotoxicity is unclear. Theoretically, the antidote may have some benefit if given > 24 h after an ingestion if residual (unmetabolized) acetaminophen is present. The following approach has not been proved effective but may be used:
Prognostic factors are similar to those in acute acetaminophen poisoning.
Last full review/revision April 2009 by Gerald F. O'Malley, DO
Content last modified April 2009
| 
